TRERE', DAVIDE
 Distribuzione geografica
Continente #
NA - Nord America 3.526
EU - Europa 2.531
AS - Asia 705
AF - Africa 187
Continente sconosciuto - Info sul continente non disponibili 20
SA - Sud America 16
OC - Oceania 6
Totale 6.991
Nazione #
US - Stati Uniti d'America 3.504
GB - Regno Unito 577
IT - Italia 507
SE - Svezia 416
CN - Cina 330
DE - Germania 277
VN - Vietnam 179
UA - Ucraina 126
IN - India 122
IE - Irlanda 120
TG - Togo 102
CH - Svizzera 98
FR - Francia 83
RU - Federazione Russa 81
ZA - Sudafrica 48
EE - Estonia 46
HR - Croazia 41
AT - Austria 39
JO - Giordania 37
BG - Bulgaria 29
PL - Polonia 28
CA - Canada 22
BE - Belgio 20
CI - Costa d'Avorio 15
EU - Europa 15
NG - Nigeria 13
FI - Finlandia 12
JP - Giappone 9
NL - Olanda 9
SC - Seychelles 9
AU - Australia 6
BR - Brasile 6
DK - Danimarca 6
GR - Grecia 6
CO - Colombia 4
PH - Filippine 4
SG - Singapore 4
A2 - ???statistics.table.value.countryCode.A2??? 3
AR - Argentina 3
HK - Hong Kong 3
IR - Iran 3
SK - Slovacchia (Repubblica Slovacca) 3
UZ - Uzbekistan 3
CL - Cile 2
CZ - Repubblica Ceca 2
KR - Corea 2
LB - Libano 2
TR - Turchia 2
XK - ???statistics.table.value.countryCode.XK??? 2
AE - Emirati Arabi Uniti 1
AM - Armenia 1
HU - Ungheria 1
ID - Indonesia 1
KW - Kuwait 1
LU - Lussemburgo 1
MD - Moldavia 1
RO - Romania 1
SI - Slovenia 1
TW - Taiwan 1
VE - Venezuela 1
Totale 6.991
Città #
Southend 513
Fairfield 454
Chandler 415
Ashburn 260
Woodbridge 242
Ann Arbor 239
Houston 231
Seattle 211
Wilmington 206
Cambridge 165
Bologna 164
Princeton 134
Dublin 120
Dong Ket 105
Lomé 102
Bern 92
Jacksonville 81
Padova 59
Westminster 55
Nanjing 51
New York 42
Redwood City 42
Berlin 40
Amman 37
Jinan 37
Turin 37
Beijing 34
Milan 34
Vienna 31
Shenyang 29
Sofia 29
Hebei 27
Nanchang 27
Saint Petersburg 24
Warsaw 24
San Diego 22
Redmond 20
Bremen 18
Brussels 18
Boardman 17
Mülheim 17
Florence 16
Abidjan 15
Changsha 15
Haikou 15
Abeokuta 13
Jiaxing 13
Olalla 13
Sherbrooke 13
Verona 13
Des Moines 11
Helsinki 11
London 11
Dallas 10
Zhengzhou 10
Dearborn 9
Mahé 9
Ningbo 8
Norwalk 8
Taiyuan 8
Boydton 7
Hangzhou 7
Kuban 7
Lanzhou 7
Pune 7
Tianjin 7
Wayne 7
Guangzhou 6
Los Angeles 6
Mountain View 6
Phoenix 6
São Paulo 6
Tokyo 6
Amsterdam 5
Falls Church 5
Hefei 5
Rome 5
Taizhou 5
Barranquilla 4
Citta 4
Como 4
Modena 4
Parma 4
Ravenna 4
Reggio Emilia 4
San Venanzo 4
Toronto 4
Angeles City 3
Aprilia 3
Bratislava 3
Chicago 3
Forlì 3
Frankfurt Am Main 3
Lagaro 3
Loreggia 3
Montréal 3
Paris 3
Roncegno 3
San Francisco 3
Shanghai 3
Totale 4.911
Nome #
A statistical model predicting high hepatocyte proliferation index and the risk of developing hepatocellular carcinoma in patients with hepatitis C virus-related cirrhosis 210
Circulating microRNAs, MIR-939, MIR-595, MIR-519d and MIR-494, identify cirrhotic patients with HCC 186
Combined expression levels of KDM2A and KDM2B correlate with nucleolar size and prognosis in primary breast carcinomas 175
The p53-mediated sensitivity of cancer cells to chemotherapeutic agents is conditioned by the status of the retinoblastoma protein. 156
The nucleolar size is associated to the methylation status of ribosomal DNA in breast carcinomas. 149
Therapeutic dosages of aspirin counteract the IL-6 induced pro-tumorigenic effects by slowing down the ribosome biogenesis rate 148
Erosions or not in GORD? The potential role of oesophageal cell proliferation 144
Different effects of ribosome biogenesis inhibition on cell proliferation in retinoblastoma protein- and p53- deficient and proficient human osteosarcoma cell lines. 142
Location of rRNA transcription to the nucleolar components: disappearance of the fibrillar centers in nucleoli of regenerating rat hepatocytes. 140
Cell proliferation of esophageal squamous epithelium in erosive and non-erosive reflux disease 140
Dyskerin expression influences the level of ribosomal RNA pseudo-uridylation and telomerase RNA component in human breast cancer. 138
SnoRNA U50 levels are regulated by cell proliferation and rRNA transcription. 135
Novel dyskerin-mediated mechanism of p53 inactivation through defective mRNA translation. 134
DKC1 Overexpression Induces a More Aggressive Cellular Behavior and Increases Intrinsic Ribosomal Activity in Immortalized Mammary Gland Cells 134
Key role of the achievement of an appropriate ribosomal RNA complement for G1-S phase transition in H4-II-E-C3 rat hepatoma cells 133
Endoscopic appearance of GERD: Putative role of cell proliferation 131
An innovative hyperbaric hypothermic machine perfusion protects the liver from experimental preservation injury 126
Esophageal cell proliferation in gastroesophageal reflux disease: clinical-morphological data before and after pantoprazole. 124
RNA pseudouridylation in physiology and medicine: For better and for worse 124
Changes in ribosome biogenesis may induce cancer by down-regulating the cell tumor suppressor potential. 123
Interferon plus ribavirin and interferon alone in preventing hepatocellular carcinoma: a prospective study on patients with HCV related cirrhosis. 123
The Ribosome Biogenesis-Cancer Connection 122
Selective inhibition of rRNA transcription downregulates E2F-1: a new p53-independent mechanism linking cell growth to cell proliferation. 121
The importance of being (slightly) modified: The role of rRNA editing on gene expression control and its connections with cancer 121
Epigenetic up-regulation of ribosome biogenesis and more aggressive phenotype triggered by the lack of the histone demethylase JHDM1B in mammary epithelial cells 121
Hyperoxia fully protects mitochondria of explanted livers 120
Strategies to Restore Adenosine Triphosphate (ATP) Level After More than 20 Hours of Cold Ischemia Time in Human Marginal Kidney Grafts. 120
The balance between rRNA and ribosomal protein synthesis up- and downregulates the tumour suppressor p53 in mammalian cells. 118
Interleukin 6 downregulates p53 expression and activity by stimulating ribosome biogenesis: a new pathway connecting inflammation to cancer. 115
Dyskerin expression in human fetal, adult and neoplastic intrahepatic bile ducts: Correlations with cholangiocarcinoma aggressiveness 114
High prevalence of retinoblastoma protein loss in triple-negative breast cancers and its association with a good prognosis in patients treated with adjuvant chemotherapy. 112
Prognostic relevance of a novel semi-quantitative classification of Bcl2 immunohistochemical expression in human infiltrating ductal carcinomas of the breast. 109
Relationship between dyskerin expression and telomerase activity in human breast cancer. 105
SARS-CoV-2/COVID-19 testing: The tower of babel 105
Relationship between the RB1 mRNA level and the expression of phosphorylated RB protein in human breast cancers: their relevance in cell proliferation activity and patient clinical outcome 104
Partial persistance of exercise-induced myocardial angiogenesis following 4-wk detraining in the rat. 103
GADD45alpha expression in cirrhosis and hepatocellular carcinoma. Relationship with DNA-repair and proliferation. 103
The basal-like breast carcinoma phenotype is regulated by SLUG gene expression 102
null 101
Nucleolar size and activity are related to pRb and p53 status in human breast cancer 98
Erosions or not in GERD? The potential role of esophageal cell kinetics 96
The emerging role of RNA polymerase I transcription machinery in human malignancy: a clinical perspective. 95
The prognostic value of the AgNOR parameter in human breast cancer depends on the pRb and p53 status 94
Correlation between the histopathological diagnosis by AgNOR count and AgNOR area in canine mammary tumors. 93
Loss of retinoblastoma tumor suppressor protein makes human breast cancer cells more sensitive to antimetabolite exposure. 92
Cell proliferation in breast cancer: a major determinant of clinical outcome in node-positive, but not in node-negative patients. 92
Controversial relationship between the expression of the RB pathway components and RB protein phosphorylation in human breast cancer 92
Nucleolus, ribosomes, and cancer. 91
Dyskerin and TERC expression may condition survival in lung cancer patients 91
null 89
JHDM1B expression regulates ribosome biogenesis and cancer cell growth in a p53 dependent manner 89
What the nucleolus says to a tumour pathologist. 87
Separated Siamese Twins: Intronic Small Nucleolar RNAs and Matched Host Genes May be Altered in Conjunction or Separately in Multiple Cancer Types 87
DKC1 gene mutations in human sporadic cancer. 86
Targeted cancer therapy with ribosome biogenesis inhibitors: A real possibility? 86
Effects of Entothelin-1 on Human Trabecular Meshwork Cell Contraction. 85
Treating hematological malignancies with drugs inhibiting ribosome biogenesis: When and why 85
null 81
Direct antiviral treatments for hepatitis c virus have off-target effects of oncologic relevance in hepatocellular carcinoma 80
Assessing the Role of Trust in Information Sources, Adoption of Preventive Practices, Volunteering and Degree of Training on Biological Risk Prevention, on Perceived Risk of Infection and Usage of Personal Protective Equipment Among Italian Medical Students During the SARS-CoV-2 Pandemic 71
Human dyskerin binds to cytoplasmic H/ACA-box-containing transcripts affecting nuclear hormone receptor dependence 65
MicroRNA expression profiling with a droplet digital PCR assay enables molecular diagnosis and prognosis of cancers of unknown primary 56
Dyskerin depletion increases VEGF mRNA internal ribosome entry site-mediated translation. 55
Direct relationship between the level of p53 stabilization induced by rRNA synthesis-inhibiting drugs and the cell ribosome biogenesis rate 49
Primer extension coupled with fragment analysis for rapid and quantitative evaluation of 5.8S rRNA isoforms 49
MicroRNAs at the Crossroad between Immunoediting and Oncogenic Drivers in Hepatocellular Carcinoma 24
Parasympathetic failure and risk of subsequent coronary events in unstable angina and non-ST-segment elevation myocardial infarction 15
Ribosome biogenesis and cancer 14
Liquid Biopsy in the Management of Breast Cancer Patients: Where Are We Now and Where Are We Going 6
Qualitative and quantitative analysis of AgNOR proteins in chemically induced rat liver carcinogenesis 3
Totale 7.227
Categoria #
all - tutte 17.329
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 17.329


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201997 0 0 0 0 0 0 0 0 0 0 32 65
2019/20201.812 231 46 21 106 183 185 232 226 267 114 94 107
2020/20211.119 195 57 20 50 46 144 48 50 118 85 68 238
2021/20221.478 130 35 79 203 108 66 35 130 25 133 330 204
2022/20231.808 155 260 115 240 98 148 77 107 295 41 123 149
2023/2024407 37 66 24 53 23 86 27 22 18 22 29 0
Totale 7.227